Aquestive Therapeutics, Inc.: capex
| Value | {"amount": 2000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8dfe893c-41e9-4baa-95da-e1c971c21c1d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-014920Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/capex/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8dfe893c-41e9-4baa-95da-e1c971c21c1d
History
- no predecessors — first report